Lipotox 30 X Liquid is a Health Canada–registered human drug (DIN 02233643) held by Bio Active Canada Ltd., containing Phosphoric Acid. Health Canada lists its status as Cancelled Post Market (status date 28 Sep 2007). Nexara Health has matched 15 registrations of Phosphoric Acid across 3 other regulated markets, 2 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02233643 |
|---|---|
| Brand name | Lipotox |
| Active ingredient | Phosphoric Acid |
| Strength | 30 X |
| Dosage form | Liquid |
| Route | Oral |
| Company | Bio Active Canada Ltd. |
| Status | Cancelled Post Market — 28 Sep 2007 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Phosphoric Acid registered in other markets
15 registrations of the same molecule in 3 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Naturasil Acne | Nature's Innovation, Inc. | Liquid | listed | FDA NDC | |
| United States | Phosphoric Acid | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Liquid | listed | FDA NDC | |
| Greece | Trifalac Oral.sol (24,4+10,8)g/45ml Btx2flx45ml | Medicus A.e. | reimbursed | MoH deltio timwn | ||
| Taiwan | Phosphoric Acid | Eli. Lilly & Co. | 原料藥溶液劑 | 已註銷 | TFDA | |
| United States | BM Phosphoric Acid | BM Private Limited | Globule | listed | FDA NDC | |
| United States | Phosphoricum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Phosphoricum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Phosphoricum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Phosphoricum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Phosphoricum acidum | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Phosphoric Acid worldwide →
Regulator price references for Phosphoric Acid
Published list or reimbursement prices for Phosphoric Acid presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Greece | Trifalac Oral.sol (24,4+10,8)g/45ml Btx2flx45ml | 45ml+45ml | 5.65 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Lipotox (DIN 02233643) marketed in Canada?
No. Health Canada lists DIN 02233643 as Cancelled Post Market as of 28 Sep 2007.
Who holds the Canadian licence for this product?
Bio Active Canada Ltd. is the company of record in the Health Canada Drug Product Database.
Is Phosphoric Acid registered outside Canada?
Yes — Nexara Health has matched 15 registrations in 3 other markets, including 2 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02233643, status date 2007-09-28; national medicine registries: FDA NDC, MoH deltio timwn, TFDA; price sources: MoH deltio timwn. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02233643, status date 2007-09-28; national medicine registries: FDA NDC, MoH deltio timwn, TFDA; price sources: MoH deltio timwn.
Health Canada Drug Product Database (DPD), DIN 02233643, status date 2007-09-28; national medicine registries: FDA NDC, MoH deltio timwn, TFDA; price sources: MoH deltio timwn. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.